Nachman Norwood & Parrott’s AbbVie ABBV Stock Holding History

Nachman Norwood & Parrott’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$3.11M	Sell	27,606 -17	-0.1%	-$1.92K	0.32%	68
2021 Q1	$2.99M	Buy	27,623 +96	+0.3%	+$10.3K	0.33%	64
2020 Q4	$2.95M	Buy	27,527 +845	+3%	+$81.2K	0.34%	59
2020 Q3	$2.34M	Sell	26,682 -245	-0.9%	-$23.1K	0.31%	69
2020 Q2	$2.64M	Buy	26,927 +3,770	+16%	+$332K	0.44%	49
2020 Q1	$1.76M	Buy	23,157 +1,632	+8%	+$139K	0.36%	68
2019 Q4	$1.91M	Buy	21,525 +711	+3%	+$59K	0.31%	68
2019 Q3	$1.58M	Buy	20,814 +301	+1%	+$20.6K	0.28%	74
2019 Q2	$1.49M	Buy	20,513 +334	+2%	+$26.3K	0.27%	74
2019 Q1	$1.63M	Buy	20,179 +376	+2%	+$30.8K	0.3%	75
2018 Q4	$1.83M	Buy	+19,803	New	+$1.74M	0.38%	62

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Nachman Norwood & Parrott's ABBV Position: Q2 2021 in Review

Nachman Norwood & Parrott reduced its AbbVie (ABBV) stake by 0.06% in Q2 2021, selling an estimated $1.92K and leaving 27,606 shares worth $3.11M. The position accounts for 0.32% of the portfolio, ranked #68.

Nachman Norwood & Parrott first reported a position in ABBV in Q4 2018 and has held it in 11 quarters since. 2,677 funds tracked by Wall St. Rank hold ABBV as of Q2 2021.

Nachman Norwood & Parrott held 27,606 shares of AbbVie worth $3.11M as of Q2 2021.
Nachman Norwood & Parrott sold 17 AbbVie shares in Q2 2021, an estimated $1.92K.
AbbVie made up 0.32% of Nachman Norwood & Parrott's portfolio in Q2 2021, its #68 holding.
Nachman Norwood & Parrott first reported a position in AbbVie in Q4 2018 and has held it in 11 quarters since.
2,677 funds tracked by Wall St. Rank held AbbVie as of Q2 2021.

Based on Nachman Norwood & Parrott's 13F filing for Q2 2021, filed 13 Aug 2021.